Pharmabiz1h
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease: Tokyo Friday, February 21, 2025, 10:00 Hr ...
Pharmabiz2h
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...
Pharmabiz3h
TN DCA tightens noose on violators of drug laws as 221 prosecutions were issued in 10 months
TN DCA tightens noose on violators of drug laws as 221 prosecutions were issued in 10 months: Peethaambaran Kunnathoor, Chennai Friday, February 21, 2025, 08:00 Hrs [IST] The drug ...
Pharmabiz3h
Pharmexcil to host seminar on market access issues for pharmaceutical
Pharmexcil to host seminar on market access issues for pharmaceutical: Shardul Nautiyal, Mumbai Friday, February 21, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promotion Cou ...
Pharmabiz3h
Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma
Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma: Nandita Vijayasimha, Bengaluru Friday, February 21, 2025, 08:00 Hrs [IST] The future ...
Pharmabiz3h
DGFT introduces mandatory online submissions & digital payments for enforcement & adjudication proceedings
DGFT introduces mandatory online submissions & digital payments for enforcement & adjudication proceedings: Shardul Nautiyal, Mumbai Friday, February 21, 2025, 08:00 Hrs [IST] In ...
Pharmabiz3h
Pharmaceuticals exports register highest growth at 21.5% in January
Pharmaceuticals exports register highest growth at 21.5% in January: Gireesh Babu, New Delhi Friday, February 21, 2025, 08:00 Hrs [IST] Exports of drugs and pharmaceuticals from I ...
Pharmabiz19h
Genprex advances diabetes programme with addition of research focused on non-viral delivery system
Genprex advances diabetes programme with addition of research focused on non-viral delivery system: Austin, Texas Thursday, February 20, 2025, 16:00 Hrs [IST] Genprex, Inc., a cli ...
Pharmabiz17h
Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent
Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...
Pharmabiz20h
Merus’ petosemtamab receives US FDA breakthrough therapy designation for 1L PD-L1 positive head and neck squamous cell carcinoma
Utrecht, The Netherlands Thursday, February 20, 2025, 15:00 Hrs [IST] ...
Pharmabiz23h
US FDA accepts Gilead’s NDA for twice-yearly lenacapavir for HIV prevention under priority review
Foster City, California Thursday, February 20, 2025, 12:00 Hrs [IST] ...
Pharmabiz21h
Global experts gather at Sir HN Reliance Hospital for an IFSO consensus conference on sleeve gastrectomy
Global experts gather at Sir HN Reliance Hospital for an IFSO consensus conference on sleeve gastrectomy: Our Bureau, Mumbai Thursday, February 20, 2025, 14:15 Hrs [IST] With an a ...